SciSparc Ltd. (SPRC)
Develops cannabinoid-based drugs for neurological disorders and chronic pain.
$5.02-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-90.2%
The outlook
SPRC is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst coverage appears minimal, and the overall sentiment leans bearish based on current market positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Market cap
$2.9M
52-wk high
$80.10
52-wk low
$2.98
50-day avg
$6.46
200-day avg
$11.49
Trailing P/E
0.1